Search Within

Computational Oncology Service

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (145)
  2. Meeting Abstract (99)
  3. Editorial (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (247)
  2. Epidemiology and Biostatistics (247)
  3. GSK Faculty (247)
  4. Genitourinary Oncology Service (247)
  5. Solid Tumor Oncology Division (247)
  6. Human Oncology and Pathogenesis Program (238)

More Groups

People
  1. Nikolaus Schultz (191)
  2. David Solit (165)
  3. Michael Berger (128)
  4. Marc Ladanyi (59)
  5. Ahmet Zehir (55)
  6. Barry Taylor (48)

More People

Years
  1. 2025 (8)
  2. 2024 (18)
  3. 2023 (16)
  4. 2022 (28)
  5. 2021 (23)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (62)
  2. Clinical Cancer Research (27)
  3. Cancer Research (21)
  4. Cancer Discovery (11)
  5. European Urology (11)
  6. JCO Precision Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (71)
  2. American Association for Cancer Research (63)
  3. Nature Publishing Group (27)
  4. Elsevier Science, Inc. (13)
  5. Oxford University Press (13)
  6. Cell Press (11)

More Publishers

Results (247)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Influence of WNT and DNA damage response pathway alterations on outcomes in patients with unresectable metastatic colorectal cancer
    Meeting Abstract

    Mondaca, S.; Walch, H. S.; Nandakumar, S.; Chatila, W. K.; Hechtman, J. F.; Cercek, A.; Diaz, L. A.; Sanchez-Vega, F.; Kemeny, N. E.; Segal, N. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O-) in HER2-positive metastatic esophagogastric adenocarcinoma (mEGA)
    Meeting Abstract

    Janjigian, Y. Y.; Chou, J. F.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; Chong, C. R.; Gerdes, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical validation of a genomics-based classifier to predict tissue of origin from targeted tumor sequencing
    Meeting Abstract

    Zheng, Y.; Penson, A. V.; Camacho, N.; Biederstedt, E.; Zehir, A.; Kandoth, C.; Syed, A.; Varghese, A. M.; Al-Ahmadie, H. A.; Schultz, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • BRCA-mediated tumorigenesis is origin and cell-type dependent
    Meeting Abstract

    Jonsson, P.; Cheng, M. L.; Bandlamudi, C.; Srinivasan, P.; Chavan, S. S.; Friedman, N. D.; Rosen, E. Y.; Richards, A. L.; Bouvier, N.; Selcuklu, S. D.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Zygosity, lineage, and penetrance dictate the role of germline pathogenicity in tumorigenesis
    Meeting Abstract

    Bandlamudi, C.; Srinivasan, P.; Jonsson, P.; Kemel, Y. M.; Chavan, S. S.; Richards, A. L.; Penson, A.; Bielski, C. M.; Fong, C.; Syed, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • AKT mutant allele-specific activation dictates pharmacologic sensitivities
    Meeting Abstract

    Shrestha Bhattarai, T.; Shamu, T.; Patel, S.; Gorelick, A.; Chang, M. T.; Gavrila, E. I.; Gao, J. J.; Donoghue, M. T.; Gao, P. S.; Soumerai, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
    Journal Article

    Ho, A. S.; Ochoa, A.; Jayakumaran, G.; Zehir, A.; Valero Mayor, C.; Tepe, J.; Makarov, V.; Dalin, M. G.; He, J.; Bailey, M.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save